Black Americans have worse stroke outcome compared with non-Hispanic whites.


Journal

Journal of the National Medical Association
ISSN: 1943-4693
Titre abrégé: J Natl Med Assoc
Pays: United States
ID NLM: 7503090

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 29 04 2023
revised: 23 06 2023
accepted: 14 08 2023
pmc-release: 01 10 2024
medline: 23 10 2023
pubmed: 28 8 2023
entrez: 27 8 2023
Statut: ppublish

Résumé

We studied racial differences in post-stroke outcomes using a prospective, population-based cohort of stroke survivors as part of the Brain Attack Surveillance in Corpus Christi (BASIC) project. Neurologic (NIHSS, range of 0-42, higher scores are worse), functional (ADLs/IADLs, range 1-4, higher scores are worse), and cognitive (3MSE, range 0-100, higher scores are better) outcomes were measured 90 days after stroke. Cox proportional hazards and negative binomial linear regression models were used to examine the associations between race and 90-day all-cause mortality and NIHSS, respectively, whereas linear regression was used for ADLs/IADLs and 3MSE scores. Covariates included demographics, initial NIHSS, comorbidities, prior stroke history, tPA treatment status, pre-stroke disability, and pre-stroke cognition. The mortality model was also adjusted for DNR status. At 90 days post-stroke, Black American individuals (BAs) (n = 122) had a median (IQR) NIHSS of 2 (1,6) compared to NIHSS of 1 (0,3) in non-Hispanic White American individuals (NHWs) (n = 795). BAs had a median (IQR) ADL/IADL score of 2.41 (1.50, 3.39) compared to 2.00 (1.27, 2.95) in NHWs. BAs scored a median of 84 (75, 92) on the 3MSE compared to NHWs' score of 91.5 (83, 96). Death occurred in 23 (8%) of BAs and 268 (15%) of NHWs within 90 days among those who participated in baseline. After adjustment for covariates, functional outcomes at 90 days were worse in BAs compared to NHWs, with 15.8% (95% CI=5.2, 26.4) greater limitations in ADLs/IADLs and 43.9% (95% CI=12.0, 84.9) greater severity of stroke symptoms. Cognition at 90 days was 6.5% (95% CI=2.4, 10.6) lower in BAs compared to NHWs. BAs had a 35.4% lower (95% CI=-9.8, 61.9) hazard rate of mortality than NHWs. In this prospective, population-based community sample, BAs had worse neurologic, functional and cognitive outcomes at 90 days compared to NHWs. Future research should investigate how social determinants of health including structural racism, neighborhood factors and access to preventive and recovery services influences these racial disparities.

Identifiants

pubmed: 37634970
pii: S0027-9684(23)00099-8
doi: 10.1016/j.jnma.2023.08.003
pmc: PMC10591825
mid: NIHMS1933469
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

509-515

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS038916
Pays : United States

Informations de copyright

Copyright © 2023 National Medical Association. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interests The authors declare there is no conflict of interests.

Références

Am J Epidemiol. 2004 Aug 15;160(4):376-83
pubmed: 15286023
Ethn Dis. 2020 Jan 16;30(1):91-96
pubmed: 31969788
Stroke. 2021 Aug;52(8):2562-2570
pubmed: 34078107
Stroke. 2008 May;39(5):1514-9
pubmed: 18340094
J Neurol Sci. 2016 Jun 15;365:203-6
pubmed: 27206907
Perspect Health Inf Manag. 2020 Dec 07;18(Winter):1i
pubmed: 33633519
Med Care Res Rev. 2012 Apr;69(2):158-75
pubmed: 21976416
Neurology. 2019 Oct 29;93(18):e1664-e1674
pubmed: 31554649
Neurology. 2014 Jul 29;83(5):390-7
pubmed: 24975857
Ann Neurol. 2011 Apr;69(4):619-27
pubmed: 21416498
Stroke. 2017 Dec;48(12):3329-3335
pubmed: 29089456
J Racial Ethn Health Disparities. 2018 Feb;5(1):117-140
pubmed: 28275996
Ann Neurol. 2023 Feb;93(2):348-356
pubmed: 36134521
J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1412-4
pubmed: 23911949
JAMA Neurol. 2020 May 1;77(5):601-605
pubmed: 32091536
Stroke. 2022 May;53(5):1711-1719
pubmed: 35172607
Neurology. 2022 Nov 29;99(22):e2464-e2473
pubmed: 36041865
Curr Cardiol Rep. 2005 Jan;7(1):29-33
pubmed: 15610644
Neurology. 2018 Jan 30;90(5):e359-e364
pubmed: 29298854
J Stroke Cerebrovasc Dis. 2019 Sep;28(9):2506-2516
pubmed: 31255440
Neurol Clin. 2008 Nov;26(4):1177-90, xi
pubmed: 19026907

Auteurs

Lewis B Morgenstern (LB)

Department of Neurology, University of Michigan Medical School, Ann Arbor; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor; Department of Emergency Medicine, University of Michigan Medical School, Ann Arbor. Electronic address: lmorgens@umich.edu.

Mellanie V Springer (MV)

Department of Neurology, University of Michigan Medical School, Ann Arbor.

Neil C Porter (NC)

Department of Neurology, University of Maryland, Baltimore.

Madeline Kwicklis (M)

Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor.

Joseph F Carrera (JF)

Department of Neurology, University of Michigan Medical School, Ann Arbor.

Cemal B Sozener (CB)

Department of Emergency Medicine, University of Michigan Medical School, Ann Arbor.

Morgan S Campbell (MS)

CHRISTUS Spohn Hospitals, CHRISTUS Health system, Corpus Christi, Texas.

Imadeddin Hijazi (I)

Department of Neurology, University of Michigan Medical School, Ann Arbor.

Lynda D Lisabeth (LD)

Department of Neurology, University of Michigan Medical School, Ann Arbor; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH